MTOR and neoplasm: The binding of insulin or free insulin-like growth factor IGF-1 to specific tyrosine kinase receptors can activate the insulin/IGF-1-PI3K-Akt-mTOR signaling pathway and enhance glycolysis and glutamine breakdown, thereby promoting tumor cell proliferation [27].